My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 716

    1.

    Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan.

    Clemenz M, Frost N, Schupp M, Caron S, Foryst-Ludwig A, Böhm C, Hartge M, Gust R, Staels B, Unger T, Kintscher U.

    Diabetes. 2008 May;57(5):1405-13. Epub 2008 Jan 9.PMID: 18184928 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Deletion of angiotensin II type I receptor reduces hepatic steatosis.

    Nabeshima Y, Tazuma S, Kanno K, Hyogo H, Chayama K.

    J Hepatol. 2009 Jun;50(6):1226-35. Epub 2009 Mar 11.PMID: 19395110 [PubMed - indexed for MEDLINE]Related articles

    3.

    Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity.

    Schupp M, Janke J, Clasen R, Unger T, Kintscher U.

    Circulation. 2004 May 4;109(17):2054-7. Epub 2004 Apr 26.PMID: 15117841 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation.

    McCarthy TC, Pollak PT, Hanniman EA, Sinal CJ.

    J Pharmacol Exp Ther. 2004 Dec;311(3):864-73. Epub 2004 Jul 20.PMID: 15265979 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Telmisartan inhibits CD4-positive lymphocyte migration independent of the angiotensin type 1 receptor via peroxisome proliferator-activated receptor-gamma.

    Walcher D, Hess K, Heinz P, Petscher K, Vasic D, Kintscher U, Clemenz M, Hartge M, Raps K, Hombach V, Marx N.

    Hypertension. 2008 Feb;51(2):259-66. Epub 2007 Dec 24.PMID: 18158351 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Inhibition of tumor necrosis factor-alpha-induced interleukin-6 expression by telmisartan through cross-talk of peroxisome proliferator-activated receptor-gamma with nuclear factor kappaB and CCAAT/enhancer-binding protein-beta.

    Tian Q, Miyazaki R, Ichiki T, Imayama I, Inanaga K, Ohtsubo H, Yano K, Takeda K, Sunagawa K.

    Hypertension. 2009 May;53(5):798-804. Epub 2009 Mar 16.PMID: 19289654 [PubMed - indexed for MEDLINE]Related articles

    7.

    A selective peroxisome proliferator-activated receptor-gamma modulator, telmisartan, binds to the receptor in a different fashion from thiazolidinediones.

    Tagami T, Yamamoto H, Moriyama K, Sawai K, Usui T, Shimatsu A, Naruse M.

    Endocrinology. 2009 Feb;150(2):862-70. Epub 2009 Jan 15.PMID: 19147680 [PubMed - indexed for MEDLINE]Related articles

    8.

    Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.

    Imayama I, Ichiki T, Inanaga K, Ohtsubo H, Fukuyama K, Ono H, Hashiguchi Y, Sunagawa K.

    Cardiovasc Res. 2006 Oct 1;72(1):184-90. Epub 2006 Jul 21.PMID: 16938288 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A.

    Cheng Y, Dharancy S, Malapel M, Desreumaux P.

    World J Gastroenterol. 2005 Dec 28;11(48):7591-6.PMID: 16437683 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.

    Tanaka T, Masuzaki H, Ebihara K, Ogawa Y, Yasue S, Yukioka H, Chusho H, Miyanaga F, Miyazawa T, Fujimoto M, Kusakabe T, Kobayashi N, Hayashi T, Hosoda K, Nakao K.

    Metabolism. 2005 Nov;54(11):1490-8.PMID: 16253638 [PubMed - indexed for MEDLINE]Related articles

    11.

    Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection.

    Dharancy S, Malapel M, Perlemuter G, Roskams T, Cheng Y, Dubuquoy L, Podevin P, Conti F, Canva V, Philippe D, Gambiez L, Mathurin P, Paris JC, Schoonjans K, Calmus Y, Pol S, Auwerx J, Desreumaux P.

    Gastroenterology. 2005 Feb;128(2):334-42.PMID: 15685545 [PubMed - indexed for MEDLINE]Related articles

    12.

    Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-gamma activation.

    Janke J, Schupp M, Engeli S, Gorzelniak K, Boschmann M, Sauma L, Nystrom FH, Jordan J, Luft FC, Sharma AM.

    J Hypertens. 2006 Sep;24(9):1809-16.PMID: 16915030 [PubMed - indexed for MEDLINE]Related articles

    13.

    Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-elicited hepatic insulin resistance via peroxisome proliferator-activated receptor-gamma activation.

    Yoshida T, Yamagishi S, Matsui T, Nakamura K, Ueno T, Takeuchi M, Sata M.

    J Int Med Res. 2008 Mar-Apr;36(2):237-43.PMID: 18380932 [PubMed - indexed for MEDLINE]Related articles

    14.

    Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-gamma dependent pathway.

    Sugimoto K, Kazdová L, Qi NR, Hyakukoku M, Kren V, Simáková M, Zídek V, Kurtz TW, Pravenec M.

    J Hypertens. 2008 Jun;26(6):1209-15.PMID: 18475159 [PubMed - indexed for MEDLINE]Related articles

    15.

    Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice.

    Fischer M, You M, Matsumoto M, Crabb DW.

    J Biol Chem. 2003 Jul 25;278(30):27997-8004. Epub 2003 Jun 5.PMID: 12791698 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity.

    Schupp M, Clemenz M, Gineste R, Witt H, Janke J, Helleboid S, Hennuyer N, Ruiz P, Unger T, Staels B, Kintscher U.

    Diabetes. 2005 Dec;54(12):3442-52.PMID: 16306360 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Inhibition of the actions of peroxisome proliferator-activated receptor alpha on obesity by estrogen.

    Jeong S, Yoon M.

    Obesity (Silver Spring). 2007 Jun;15(6):1430-40.PMID: 17557980 [PubMed - indexed for MEDLINE]Related articles

    18.

    Regulation of prostate cancer cell growth and PSA expression by angiotensin II receptor blocker with peroxisome proliferator-activated receptor gamma ligand like action.

    Ishiguro H, Ishiguro Y, Kubota Y, Uemura H.

    Prostate. 2007 Jun 15;67(9):924-32.PMID: 17440964 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effect of telmisartan, angiotensin II receptor antagonist, on metabolic profile in fructose-induced hypertensive, hyperinsulinemic, hyperlipidemic rats.

    Kamari Y, Harari A, Shaish A, Peleg E, Sharabi Y, Harats D, Grossman E.

    Hypertens Res. 2008 Jan;31(1):135-40.PMID: 18360028 [PubMed - indexed for MEDLINE]Related articles

    20.

    Peroxisome proliferator-activated receptor alpha protects against obesity-induced hepatic inflammation.

    Stienstra R, Mandard S, Patsouris D, Maass C, Kersten S, Müller M.

    Endocrinology. 2007 Jun;148(6):2753-63. Epub 2007 Mar 8.PMID: 17347305 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity